Zhejiang Xinguang Pharmaceutical Co., Ltd. (300519.SZ)

CNY 14.39

(-0.14%)

Market Cap (In CNY)

2.3 Billion

Revenue (In CNY)

270.39 Million

Net Income (In CNY)

64.35 Million

Avg. Volume

3.43 Million

Currency
CNY
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
8.45-17.9
PE
-
EPS
-
Beta Value
0.256
ISIN
CNE1000027T3
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Yue Jun Wang
Employee Count
-
Website
https://www.xgpharma.com
Ipo Date
2016-06-24
Details
Zhejiang Xinguang Pharmaceutical Co., Ltd. engages in the research and development, production, and sales of Chinese patent medicines, chemical medicines, and health foods. The company offers pharmaceutical products in the areas of cardiovascular and cerebrovascular diseases, and traumatic diseases, covering the aspects of respiratory system, digestive system, urinary system, pediatric diseases, and improving immunity. It also can produce 6 dosage forms with 49 approval numbers for drug production and 2 approval numbers for health food. It offers its products in the form of tablets, granules, syrups, powders, hard capsules, and oral solutions, as well as mixtures, including oral liquids. Zhejiang Xinguang Pharmaceutical Co., Ltd. was founded in 1970 and is headquartered in Shengzhou, China.